SMALL CAP SIREN

Delisting tracker · as of Nov 2, 2026

Estrella Immunopharma, Inc. ($ESLA): exchange listing notices

Nasdaq · Deficiency notice · market value of listed securities, stockholders' equity

Compliance deadline: Mar 1, 2027 · 119 days

From the company's 8-K Item 3.01 filings on SEC EDGAR (CIK 1844417). Read each filing before relying on it; our parsing can be wrong. All companies on the tracker → · JSON: /api/v1/tracker?ticker=ESLA

Item 3.01 filings, newest first

1. Sep 8, 2026: Deficiency notice

   Nasdaq deficiency notice: market value of listed securities, stockholders' equity; deadline March 1, 2027; hearing/appeal available; request not stated.

   Notice date Sep 1, 2026 · Compliance deadline Mar 1, 2027

   Read the 8-K on sec.gov →
2. Aug 21, 2026: Deficiency notice

   Nasdaq deficiency notice: minimum bid price; deadline February 16, 2027.

   Notice date Aug 17, 2026 · Compliance deadline Feb 16, 2027

   Read the 8-K on sec.gov →